Evolvement of european union regulations on innovative medicines

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-RSC-001
• By: AGIUS, Roberta (Malta)
• Co-author(s): Roberta Agius: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
  Francesca Wirth: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
  Anthony Serracino Inglott: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
  
• Abstract:

  Background

  Regulatory requirements are a major reason affecting access to innovative medicines (IM). 

  Purpose

  To study the impact of European Union (EU) regulation regarding IM by investigating authorisation procedures. 

  Methods

  Analysis of EU regulatory tools developed to facilitate access to IM was undertaken. Conditional (CMA) and exceptional..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login